Figure 2
From: Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
Evaluation of the add-on value of the QIAseq unique region in the detection of clinically significant variants. (a) No. of variants per patient detected by QIAseq whole panel region and unique panel region. (b) The clinical significance of genes that are detected by the unique panel region of QIAseq for all cohorts from TCGA at all stages.
